Arun Bahadur Gurung

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach

Arun Bahadur Gurung, M. Ajmal Ali, Joongku Lee et al. · Life Sciences · 2020 · 152 citations · Full text

Silico Approach, Medicine, Antiviral Drug Development +9

RETRACTED: Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets

Arun Bahadur Gurung, M. Ajmal Ali, Joongku Lee et al. · PLoS ONE · 2021 · 82 citations · Full text

Exploring the physicochemical profile and the binding patterns of selected novel anticancer Himalayan plant derived active compounds with macromolecular targets

Arun Bahadur Gurung, Atanu Bhattacharjee, M. Ajmal Ali · Informatics in Medicine Unlocked · 2016 · 73 citations · Full text

Drug Target, Chemical Biology, Pharmaceutical Chemistry +18

In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors

Arun Bahadur Gurung · Gene Reports · 2020 · 70 citations · Full text

Silico Structure Modelling, Engineering, Antiviral Compound +11

Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme

Arun Bahadur Gurung, M. Ajmal Ali, Joongku Lee et al. · Journal of King Saud University - Science · 2020 · 51 citations · Full text